Your session is about to expire
← Back to Search
Patient-centered communication of life expectancy for Prostate Cancer
N/A
Waitlist Available
Led By Timothy Daskivich, MD, MSHPM
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at time of treatment decision, up to 12 weeks after diagnosis
Awards & highlights
Study Summary
This trial will test if telling patients their life expectancy helps them make better decisions about treatment for genitourinary cancers.
Eligible Conditions
- Prostate Cancer
- Kidney Cancer
- Bladder Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at time of treatment decision, up to 12 weeks after diagnosis
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at time of treatment decision, up to 12 weeks after diagnosis
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Decisional Conflict
Secondary outcome measures
Mention of life expectancy
Number of questions asked about life expectancy
Time devoted to life expectancy
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Intervention: (1) Subjects will be provided with patient-specific LE estimates, (2) counseling physicians will receive "talking points" to assist in meaningful communication of life expectancy, and (3) subjects will complete a computer-based conjoint analysis exercise prior to counseling.
Group II: Standard-of-care ArmActive Control1 Intervention
Patients in the standard-of-care arm will not receive an intervention and will receive the usual standard of care for treatment counseling.
Find a Location
Who is running the clinical trial?
Cedars-Sinai Medical CenterLead Sponsor
500 Previous Clinical Trials
164,763 Total Patients Enrolled
13 Trials studying Prostate Cancer
2,147 Patients Enrolled for Prostate Cancer
Timothy Daskivich, MD, MSHPMPrincipal InvestigatorCedars-Sinai Medical Center
1 Previous Clinical Trials
192 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have trouble communicating or have dementia.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention Arm
- Group 2: Standard-of-care Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the maximum capacity of individuals who can partake in this research?
"Correct. According to clinicaltrials.gov, this medical trial which was initially advertised on September 1st 2021 is still recruiting patients for participation. A total of 136 participants have been requested from a single site."
Answered by AI
Are there any opportunities to take part in this medical investigation currently?
"According to the clinicaltrials.gov portal, this medical study is actively enlisting participants. The trial was initially listed on September 1st 2021 and underwent its latest edit on February 5th 2020."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger